NIH Reviews Cancer and Health Grants in Closed Sessions
Published Date: 9/4/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in October 2025 to review important grant applications related to cancer research, musculoskeletal health, and biomedical imaging. These meetings protect private info and trade secrets while deciding which projects get funding. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or new costs.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
NIH Closed Grant Review Meetings
The NIH Center for Scientific Review will hold virtual, closed meetings on specific dates in October 2025 (October 1-2; 7-8; 9-10; 14-15; 15-16; 22-23; and 29-30) to review and evaluate grant applications in areas like cancer, musculoskeletal health, imaging, infectious diseases, and Alzheimer’s research. These meetings are closed to the public, protect confidential trade secrets and personal information, and affect scientists and researchers applying for NIH grants but do not create new costs or public-attendance opportunities.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-16938 — Notice of Petition for Waiver of Compliance
American Heritage Railways, representing three scenic railroads, asked for a break from some rules about reporting injuries and keeping records. This change could make their paperwork easier and faster without risking safety. If approved, it might save time and money while keeping trains running smoothly.
Next: 2025-16940 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in October 2025 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants and NIH staff are the main players, with no changes to timing or money announced.